Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elvira Pelosi

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Leukemia & Lymphoma|September 23, 2014
MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemiasUgo Testa, Elvira Pelosi
Leukemia Research and Treatment|August 13, 2013
The Impact of FLT3 Mutations on the Development of Acute Myeloid LeukemiasUgo Testa, Elvira Pelosi
Advances in Experimental Medicine and Biology|July 17, 2024
Function of PML-RARA in Acute Promyelocytic LeukemiaUgo Testa, Elvira Pelosi
Mediterranean Journal of Hematology and Infectious Diseases|September 19, 2022
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic MalignanciesUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|August 1, 2018
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem CellsUgo Testa, Germana Castelli, Elvira Pelosi
Leukemia Research|June 2, 2009
MicroRNAs in normal and malignant myelopoiesisElvira Pelosi, Catherine Labbaye, Ugo Testa
Annali Dell'Istituto Superiore Di Sanita|December 19, 2019
Understanding mechanisms of cancer initiation and development supports the need for an implementation of primary and secondary cancer preventionElvira Pelosi, Germana Castelli, Ugo Testa
Medical Sciences (Basel, Switzerland)|March 27, 2020
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|April 14, 2025
Recent Developments in Differentiation Therapy of Acute Myeloid LeukemiaUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|May 14, 2025
Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic MalignanciesUgo Testa, Germana Castelli, Elvira Pelosi
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|September 23, 2014
MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemiasUgo Testa, Elvira Pelosi
Leukemia Research and Treatment|August 13, 2013
The Impact of FLT3 Mutations on the Development of Acute Myeloid LeukemiasUgo Testa, Elvira Pelosi
Advances in Experimental Medicine and Biology|July 17, 2024
Function of PML-RARA in Acute Promyelocytic LeukemiaUgo Testa, Elvira Pelosi
Mediterranean Journal of Hematology and Infectious Diseases|September 19, 2022
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic MalignanciesUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|August 1, 2018
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem CellsUgo Testa, Germana Castelli, Elvira Pelosi
Leukemia Research|June 2, 2009
MicroRNAs in normal and malignant myelopoiesisElvira Pelosi, Catherine Labbaye, Ugo Testa
Annali Dell'Istituto Superiore Di Sanita|December 19, 2019
Understanding mechanisms of cancer initiation and development supports the need for an implementation of primary and secondary cancer preventionElvira Pelosi, Germana Castelli, Ugo Testa
Medical Sciences (Basel, Switzerland)|March 27, 2020
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|April 14, 2025
Recent Developments in Differentiation Therapy of Acute Myeloid LeukemiaUgo Testa, Germana Castelli, Elvira Pelosi
Cancers|May 14, 2025
Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic MalignanciesUgo Testa, Germana Castelli, Elvira Pelosi
Pageof 11